Tickwind
TodayOpportunitiesMarketsHotNewsAI Chat
What's new
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/Compare

IBM vs ORCL

IBM and ORCL side by side — valuation & fundamentals (public data).

Key statistics

IBM vs ORCL key statistics
MetricIBMINTERNATIONAL BUSINESS MACHINES CORPORCLOracle Corporation
Market cap$217.96B$406.64B
P/E (TTM)20.5—
P/B6.33—
P/S3.2x—
Dividend yield2.87%—
Revenue$69.09B(TTM)—
Revenue growth (YoY)7.6%—
Net income$10.72B(TTM)—
Earnings growth (YoY)75.9%—
EPS, diluted$11.29(TTM)—
EBIT margin18.2%—
ROE30.7%—
ROIC13.1%—
Piotroski F7/9—
1y total return-1.6%-37.4%

Figures from SEC filings · for reference only · not investment advice

Growth of $10,000: IBM vs ORCL

$10.0K$24.5K$41.3K2016-04-292026-09-01
MetricIBMORCL
End value$24.5K$41.3K
Total return+144.9%+313.2%
CAGR+9.1%+14.7%
Volatility28.0%35.5%
Sharpe0.310.45
Sortino0.430.70
Max drawdown-40.6%-64.6%

Based on 2600 common trading days, 2016-04-29 → 2026-09-01 · risk-free 3.92% (current short-Treasury, held constant)

A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.

Related comparisons

ORCL vs MSFTGOOGL vs ORCLCRM vs ORCLCRM vs IBMADBE vs ORCLAAPL vs MSFT

Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)